(1)
B.M.S.R. Nayakar; Muddu Surendra Nehru. To Evaluate the Efficacy and Safety Profile of Rosuvastatin, Simvastatin and Atorvastatin in Newly Diagnosed Type 2 Diabetic Patients With Dyslipidaemia. Int. J. Heal. Clin. Res. 2021, 4, 321-325.